Skip to content
Screener

Castle Biosciences CSTL Unrealized Gain (Loss) on Equity Securities

Unrealized Gain (Loss) on Equity Securities at other companies

Royalty Pharma logo
Royalty PharmaRPRX
-$20.17M+56.0%
EQT Corporation logo
EQT CorporationEQT
$77.51M+193%
Western Digital logo
Western DigitalWDC
$2.73B+551%
Xylem logo
XylemXYL
$0-100%
Atmos Energy logo
Atmos EnergyATO
$43.5K-95.1%
United Airlines Holdings logo
United Airlines HoldingsUAL
-$13M+38.1%

Segments

By segment

See full
Reportable Segment$2.02M+242%

Other financials

Income statement

See full
Revenue$83.7M-4.9%
Gross profit$63.1M-11.8%
Operating income-$18.4M+34.1%
Net income-$14.5M+43.8%
EPS (diluted)-$0.49+45.6%

Balance sheet

See full
Cash & equivalents$63.8M-28.9%
Total debt$36.7M+42.1%
Total equity$461.4M+4.8%
Total assets$547.8M+9.2%

Cash flow

See full
Operating cash flow-$22.1M-267%
CapEx$12.5M+163%
Free cash flow-$34.6M-221%

Valuation

See full
Market cap$978.5M+76.1%
Enterprise value$951.46M+86.2%
P/S2.9×+1.3×

Profitability

See full
Gross margin77.9%-4.1pp
Operating margin-9.8%-30.8pp
Net margin-3.8%-10.2pp
FCF margin1.3%-10.7pp

Returns & leverage

See full
Return on equity-2.8%-10.6pp
Debt / equity0.1×0.0×
Current ratio6.7×-2.6×